BioInvent and Transgene Announce Poster Presentation on BT-001, a Novel Antibody-Encoding Oncolytic Virus, at AACR 2022
Accesswire
*Preclinical Data Shows the Robust Anti-Tumoral Activity of BT-001, Including Its Highly Effective and Safe Therapeutic Strategy of..